Literature DB >> 16894402

Links between Alzheimer's disease and diabetes.

Miao-Kun Sun1, Daniel L Alkon.   

Abstract

The existence of links between Alzheimer's disease and diabetes is an important topic currently under active debate. Establishing such links if they exist and defining their common pathogenesis and pathophysiological mechanisms may lead to new concepts and research directions for the pharmacological treatment of Alzheimer's disease and diabetes. Alzheimer's disease is associated with peripheral and central insulin abnormalities. Cognitive capacities are often impaired in patients with diabetes. There are many mechanisms by which insulin-signaling abnormalities may affect clinical and pathological outcome of Alzheimer's disease. Insulin resistance and dysregulation of the degradation of neurotoxic amyloid and insulin appear at the core of the links between Alzheimer's disease and diabetes. Functions and expression of insulysin, an enzyme involved in the degradation of neurotoxic amyloid peptides and insulin, are usually impaired or reduced in Alzheimer's disease and diabetes. The increased occurrence of insulin resistance in Alzheimer's disease suggests that improving insulin effectiveness and insulysin activity may have therapeutic value in Alzheimer's disease patients and therefore is worth intensive investigation. (c) 2006 Prous Science. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16894402     DOI: 10.1358/dot.2006.42.7.973588

Source DB:  PubMed          Journal:  Drugs Today (Barc)        ISSN: 1699-3993            Impact factor:   2.245


  16 in total

Review 1.  Neuronutrition and Alzheimer's disease.

Authors:  Balenahalli N Ramesh; T S Sathyanarayana Rao; Annamalai Prakasam; Kumar Sambamurti; K S Jagannatha Rao
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Actions of β-amyloid protein on human neurons are expressed through the amylin receptor.

Authors:  Jack H Jhamandas; Zongming Li; David Westaway; Jing Yang; Simran Jassar; David MacTavish
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 3.  Thyroid hormone's role in regulating brain glucose metabolism and potentially modulating hippocampal cognitive processes.

Authors:  V Jahagirdar; E C McNay
Journal:  Metab Brain Dis       Date:  2012-03-23       Impact factor: 3.584

Review 4.  Overlapped metabolic and therapeutic links between Alzheimer and diabetes.

Authors:  Waqar Ahmad
Journal:  Mol Neurobiol       Date:  2012-09-26       Impact factor: 5.590

Review 5.  Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes.

Authors:  Ewan C McNay; Andrew K Recknagel
Journal:  Neurobiol Learn Mem       Date:  2011-08-30       Impact factor: 2.877

Review 6.  Linking cardiometabolic disorders to sporadic Alzheimer's disease: a perspective on potential mechanisms and mediators.

Authors:  Narayan R Bhat
Journal:  J Neurochem       Date:  2010-09-28       Impact factor: 5.372

Review 7.  Metabolic syndrome as a risk factor for neurological disorders.

Authors:  Akhlaq A Farooqui; Tahira Farooqui; Francesco Panza; Vincenza Frisardi
Journal:  Cell Mol Life Sci       Date:  2011-10-15       Impact factor: 9.261

8.  Expression of metalloprotease insulin-degrading enzyme insulysin in normal and malignant human tissues.

Authors:  Christina Yfanti; Karin Mengele; Apostolos Gkazepis; Gregor Weirich; Cecylia Giersig; Wen-Liang Kuo; Wei-Jen Tang; Marsha Rosner; Manfred Schmitt
Journal:  Int J Mol Med       Date:  2008-10       Impact factor: 4.101

9.  Increased tau phosphorylation and impaired brain insulin/IGF signaling in mice fed a high fat/high cholesterol diet.

Authors:  Narayan R Bhat; Lakshmi Thirumangalakudi
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  Hidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses.

Authors:  Anatoliy I Yashin; Fang Fang; Mikhail Kovtun; Deqing Wu; Matt Duan; Konstantin Arbeev; Igor Akushevich; Alexander Kulminski; Irina Culminskaya; Ilya Zhbannikov; Arseniy Yashkin; Eric Stallard; Svetlana Ukraintseva
Journal:  Exp Gerontol       Date:  2017-10-26       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.